Hemorrhage caused by antiangiogenic therapy within previously irradiated areas
Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy
Gene regulatory networks
Testing new regimens in patients with advanced soft tissue sarcoma
Cancer-related fatigue
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
Expression of androgen receptor in breast cancer and its significance as a prognostic factor
Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods
FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
The efficacy of HER2-targeted agents in metastatic breast cancer
Estrogen receptor-positive breast cancer in Japanese women
HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer
Carbohydrate intake, glycemic load, glycemic index, and risk of ovarian cancer
Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can)
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer
Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma
Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma
Bevacizumab increases the risk of arterial ischemia
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer
Survival in cancer patients with previous hospitalization for sarcoidosis
Population attributable fraction of infection-related cancers in Korea
Incidence trends of melanoma of the skin compared with other localisations, in the Norwegian population, 1956–2005
Compliance with Good Clinical Practice in oncology registration trials in Japan
Medical oncology recognized at EU level to allow free movement of doctors
Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients
Massage therapy for breast cancer patients
Adjuvant! Online does not significantly influence adjuvant chemotherapy decisions of a breast cancer multidisciplinary team (MDT)
Different hepatitis B carrier categories need different management strategies in case of immunosuppressive chemotherapeutic regimens
Rituxan is not associated with Stevens Johnson Syndrome
Second neoplasms after cancers of unknown primary
Cost-utility and expected value of perfect information related to trabectedin in the treatment of metastatic soft-tissue sarcoma
Is FISH floating or still swimming in the lung cancer ocean?